MAUDE Adverse Event Report: ABBOTT LABORATORIES ARCHITECT ANTI-TPO; ANTI-TPO THYROPEROXIDASE AUTOANTIBODY

Catalog Number 02K47-20

Device Problem High Test Results (2457)

Patient Problem No Known Impact Or Consequence To Patient (2692)

Event Type  malfunction  

Manufacturer Narrative

An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.All available patient information was included.Additional patient details are not available.Refe to manufacturer report number 1415939-2019-00194 for the anti-tg submission.

Event Description

The customer reported a falsely increased architect anti-tg and anti-tpo results on one patient diagnosed with hashimoto's thyroiditis.Results provided: anti-tpo = 263.3 iu/ml (ref range: <5.61 iu/ml); anti-tg = 622.1 iu/ml (reference range: <4.11 iu/ml).Additional testing provided: tsh = 2.192 miu/ml (reference range: 0.35-4.94 miu/ml); t4 = 76.8 nmol/l (reference range: 62.68-150.84 nmol/l); ft4 = 10.1 pmol/l (reference range: 9.01-19.05 pmol/l); t3 = 1.32 nmol/l (reference range: 0.89-2.44 nmol/l); ft3 = 3.95 pmol/l (reference range: 2.63-5.70 pmol/l).There was no information as to the impact of patient health reported.Customer reported incorrect treatment was provided for the last six months from initial testing.Requested further clarification from customer regarding this issue.To be conservative, will make ticket an adverse event pending further information from the customer.

Manufacturer Narrative

The account provided additional information which makes the previously reported issue non-reportable.On the initial report there was no information provided as to the impact to patient health.Additional information was received from the account verifying there was no impact to patient health and therefore no evidence an adverse event occurred.This additional information renders the decision of this complaint not an adverse event and not reportable.No further follow-up will be provided.

• Brand Name: ARCHITECT ANTI-TPO
• Type of Device: ANTI-TPO THYROPEROXIDASE AUTOANTIBODY
• Manufacturer (Section D): ABBOTT LABORATORIES; 100 abbott park road; abbott park IL 60064 3500
• MDR Report Key: 9100665
• MDR Text Key: 214628757
• Report Number: 1415939-2019-00193
• Device Sequence Number: 1
• Product Code: JZO
• Combination Product (y/n): N
• Number of Events Reported: 1
• Summary Report (Y/N): N
• Report Source: Manufacturer
• Source Type: foreign,health professional
• Type of Report: Initial,Followup
• Report Date: 10/02/2019

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: Yes
• Device Operator: Health Professional
• Device Catalogue Number: 02K47-20
• Device Lot Number: 36812UN18
• Was Device Available for Evaluation?: No
• Initial Date Manufacturer Received: 08/21/2019
• Initial Date FDA Received: 09/20/2019
• Supplement Dates Manufacturer Received: 09/25/2019
• Supplement Dates FDA Received: 10/02/2019
• Is This a Reprocessed and Reused Single-Use Device?: No
• Patient Sequence Number: 1
• Treatment: ARCHITECT I2000SR ANALYZER LIST 03M74-02; ARCHITECT I2000SR ANALYZER LIST 03M74-02; SERIAL (B)(4); SERIAL (B)(4)
• Patient Outcome(s): Other